HYTN Innovations Inc. announces that its wholly owned subsidiary, HYTN Cannabis Inc., has received a license amendment from Health Canada allowing for the cultivation of cannabis. This License Amendment further strengthens HYTN's regulatory approvals which include a Standard Processing License, a Research License and an Amendment for Sale of Cannabis to provincially and territorially authorized retailers.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 CAD | +6.06% | +29.63% | +400.00% |
03-26 | HYTN Innovations Inc. announced that it has received CAD 0.74855 million in funding | CI |
02-29 | HYTN Innovations Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+400.00% | 18.72M | |
+1.40% | 46.35B | |
+18.85% | 23.39B | |
+48.43% | 22.18B | |
-12.03% | 16.6B | |
+19.57% | 12.98B | |
+3.86% | 11.29B | |
+22.45% | 11.24B | |
+6.37% | 9.3B | |
+45.96% | 6.18B |
- Stock Market
- Equities
- HYTN Stock
- News HYTN Innovations Inc.
- HYTN Secures Cannabis Cultivation License to Elevate the Quality of Its Cannabis Inputs